Impact of an antibiotic policy on antibiotic use in a paediatric department. Individual based follow-up shows that antibiotics were chosen according to diagnoses and bacterial findings

International Journal of Antimicrobial Agents

Volumn 20, Issue 5, 2002, Pages 333-338

  Berild, Dag ^a   Ringertz, Signe Holta ^a   Aabyholm, Gunnar ^a   Lelek, Michaela ^a   Fosse, Brita ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antibiotics; Children; Costs; Drug utilisation; Guidelines; Intervention

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; PENICILLIN G; PENICILLIN V; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE POLICY; HOSPITAL DEPARTMENT; HOSPITAL RUNNING COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NORWAY; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; DRUG COST; DRUG UTILIZATION; ECONOMICS; STANDARD; TIME;

ANTI-INFECTIVE AGENTS; CHILD; DRUG COSTS; DRUG UTILIZATION; GUIDELINE ADHERENCE; HUMANS; NORWAY; PEDIATRICS; PRACTICE GUIDELINES; TIME FACTORS;

EID: 0036844746     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00203-0     Document Type: Article

References (26)

1. Bonati M. Epidemiologic evaluation of drug use in children. J. Clin. Pharmacol. 34:1994;300-305.
2. Cunin C.M. Resistance to antimicrobial drugs - a worldwide calamity. Ann. Int. Med. 118:1993;557-561.
3. Rivero M., Padilla B., Garcia-Lechuz J., Menarguez M.C., Rodriguez-Creixems M., Bouza E. Use and misuse of antimicrobial agents in a general hospital in the AIDS era. J. Hosp. Infect. 46:2000;230-235.
4. Van Houten M.A., Laseur M., Kimpen J.L.L. Shift in antibiotic prescribing pattern in relation to antibiotic expenditures in paediatrics. Eur. J. Pediatr. 157:1998;479-481.
5. Fonseca S.N., Ehrenkranz R.A., Baltimore R.S. Epidemiology of antibiotic use in a neonatal intensive care unit. Infect. Control. Hosp. Epidemiol. 15:1994;156-162.
6. Finnish Study Group for Antimicrobial Resistance, Seppala H., Klaukka T., Vuopio-Varkila J., et al. The effect of consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. New Engl. J. Med. 337:1997;441-446.
7. de Man P., Verhoeven B.A.N., Verbrugh H.A., Vos M.C., van den Anker J.N. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 355:2000;973-978.
8. Abrahamsen T.G., Alsaker T., Fjærli H.O., Flægstad T. Diagnostikk og behandling av infeksjoner hos barn. (Diagnoses and treatment of infections in children). 1994;Norwegian Paediatric Society, Oslo.
9. Toltzis P., Rosolowski R.T., Salvator M.S. Etiology of fever and opportunities for reduction of antibiotic use in a pediatric intensive care unit. Infect. Control. Hosp. Epidemiol. 22:2001;499-504.
10. Lindbæk M., Berild D., Straand J., Hjortdahl P. Influence of prescription patterns in general practice on anti-microbial resistance in Norway. Br. J. Gen. Pract. 49:1999;436-440.
11. Gladstone I.M., Ehrenkranz R.A., Edberg S.C., Baltimore R.S. A 10-year review of neonatal sepsis and comparison with previous 50-year experience. Pediatr. Infect. Dis. 106:1990;819-825.
12. Øydvin K., Drug consumption in Norway. 1997;WHO Collaborating Center for Drug Statistics, Oslo.
13. Kolar J.V., Kadakova E. Prescription of antimicrobial drugs to hospitalised children. Ann. Pharmacother. 27:1993;974-977.
14. Boredron J.C., Laugier J., Ramponi N., Saliba E., Gold F., Blond M.H. Surveillance de l'àntibiotherapie en unite pediatrique de soins intensifs. Reanim. Soins Intensifs Med. Urgence. 8:1992;69-78.
15. Hammerschlag M.R., Klein J.O., Herschel M., Chen F.C., Fermin R. Patterns of use of antibiotics in two newborn nurseries. New Engl. J. Med. 296:1977;1268-1269.
16. Naqvi S.H., Dunkle L.M., Timmerman K.J., Reicley R.M., Stanley D.L., O'Connor D. Antibiotic usage in a paediatric medical center. J. Am. Med. Assoc. 242:1979;1981-1984.
17. Townsend T.R., Shapiro M., Rosner B., Kass E.H. Use of antimicrobial drugs in general hospitals; IV. Infants and children. Paediatrics. 65:1979;573-578.
18. Sadow K.B., Derr R., Teach S.J. Bacterial infections in infants 60 days and younger. Arch. Pediatr. Adolesc. Med. 153:1999;611-614.
19. Jarvis W.R. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect. Control. Hosp. Epidemiol. 17:1996;490-495.
20. Powell K.R. Antimicrobial therapy for suspected sepsis in infants less than 3 months of age. Pediatr. Infect. Dis. 11:1992;143-145.
21. Cordero L., Sananes M., Ayers L.W. Bloodstream infections in neonatal intensive-care unit: 12 years experience with an antibiotic control program. Infect. Control. Hosp. Epidemiol. 20:1999;242-246.
22. Pallares R., Dick R., Wenzel R.P., Adams J.R., Nettelman M.D. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978-1992). Infect. Control. Hosp. Epidemiol. 1993:14;376-382.
23. Harvey K., Hemming M., Moulds R. Use of antibiotics in a large teaching hospital. The impact of guidelines. Med. J. Aust. 2:1983;217-221.
24. Lee K.R., Legiadro R.J., Burch K.J. Drug use evaluation of antibiotics in a paediatric teaching hospital. Infect. Control. Hosp. Epidemiol. 15:1994;710-712.
25. Schentag J.J., Ballow C.H., Fritz A.L., et al. Changes in antimicrobial usage resulting from interactions among clinical pharmacy, the infectious disease division and the microbiology laboratory. Diagn. Microbiol. Infect. Dis. 16:1993;255-264.
26. Saez-Llorens X., De Wong M.M.C., Castano E., De Suman O., De Moros D., De Atenico I. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a paediatric institution in a developing country. Pediatr. Infect. Dis. J. 19:2000;200-206.